EQT Private Equity to sell Fertin Pharma to Philip Morris International
· EQT Private Equity to sell Fertin Pharma, a leading specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International for a headline Enterprise Value of DKK 5.1 billion · Fertin Pharma’s products enable people to live healthier lives – supporting millions of customers with reducing and quitting harmful cigarette smoking, and easier-to-consume oral care products, among other platforms · Under EQT Private Equity’s ownership, Fertin Pharma has continued and strengthened its transformation